The plant auxin binding receptor, TIR1, recognizes proteins containing a specific auxin-inducible degron (AID) motif in the presence of auxin, targeting them for degradation. This system is exploited in many non-plant eukaryotes, such that a target protein, tagged with the AID motif, is degraded upon auxin addition. The level of TIR1 expression is critical; excessive expression leads to degradation of the AID-tagged protein even in the absence of auxin, whereas low expression leads to slow depletion. A β-estradiol-inducible AID system was created, with expression of TIR1 under the control of a β-estradiol inducible promoter. The level of TIR1 is tunable by changing the time of incubation with β-estradiol before auxin addition. This protocol describes how to rapidly deplete a target protein using the AID system. The appropriate β-estradiol incubation time depends on the abundance of the target protein. Therefore, efficient depletion depends on optimal timing that also minimizes auxin-independent depletion.
Introduction
Conditional mutations, such as temperature-sensitive mutants, are a powerful tool for the study of essential proteins, allowing cell growth under the permissive condition but causing loss of function under non-permissive conditions. However, cell metabolism can be seriously perturbed by the change in growth conditions required to induce the defect and may also create off-target effects. Several methods have been developed, in which the protein of interest is conditionally sequestered 1 or its expression is controlled 2,3 by addition of a small molecule. This protocol uses auxin and the auxin-inducible degron (AID) system to efficiently deplete a target protein.
The AID system has its origin in plants, where an auxin (in this protocol indole-3-acetic acid (IAA) is used), stimulates interaction of the Aux/ IAA protein with TIR1, a member of the SCF U3 ubiquitin ligase complex 4 . SCF complex interaction causes polyubiquitination of Aux/IAA family proteins, which results in their degradation by the proteasome 5, 6 . This system was previously adapted for use in the yeast Saccharomyces cerevisiae 7, 8 by expressing the TIR1 protein from Oriza sativa (osTIR) in yeast cells, where it is able to interact with the endogenous yeast SCF complex. The protein of interest was tagged with a motif from the Aux/ IAA protein IAA17 to target it for degradation. Functional truncations of IAA17 were developed later, such as AID* 8, 9, 10 , containing the 43 amino acid auxin-sensitive motif from Arabidopsis thaliana IAA17, along with an epitope tag to enable detection.
The system initially adapted for use in budding yeast 7, 8 expressed the osTIR1 protein from a yeast GAL promoter. Expression requires shifting to growth medium with galactose as the sole carbon source, which, unfortunately, results in a diauxic shift with wide-ranging changes to cell metabolism 11 . On the other hand, it has been reported that constitutive expression of TIR1 can lead to degradation of the target protein in the absence of auxin/IAA 12 if the expression level is high, whereas low TIR1 expression causes inefficient depletion. An improved AID system named β-est AID was developed in which the osTIR is under the control of an inducible promoter that is tunable to suit the target protein, with minimal effect on cell metabolism. To achieve this, an artificial transcription factor (ATF) was constructed in which the VP16 viral transcription activator is fused to an oestrogen receptor and a four Zn fingers DNA binding domain (DBD). When β-estradiol (an oestrogen) is present, the ATF can enter the nucleus and induce osTIR transcription by binding to its promoter (Z4EVpr) 13, 12 . osTIR expression is usually detectable about 20 min after addition of β-estradiol 12 . However, the optimal duration of osTIR expression to achieve efficient depletion of the tagged protein with auxin, while avoiding depletion before auxin addition, needs to be empirically determined for each target protein. An approximate time for this pre-incubation can be estimated from abundance values in the Saccharomyces Genome Database (SGD https://www.yeastgenome.org/). As can be seen in Figure 1 , the abundant protein, Dcp1 (2880 to 4189 molecules/cell), requires 40 min of pre-incubation with β-estradiol, with no auxin-independent depletion observed. The much less abundant protein, Prp2 (172 to 211 molecules/ cell), is strongly depleted after only 20 min of pre-incubation. It is advisable to test two additional pre-incubation times, 10 to 20 min before or Copyright © 2019 Creative Commons Attribution 3.0 License July 2019 | 149 | e59874 | Page 2 of 8 after this initial estimated time (20 min is the minimum time that is recommended). The optimum pre-incubation time is the time at which target protein has not depleted before adding auxin and once auxin is added the depletion is acceptable or protein levels approach the minimum possible. So, from Figure 1b , for Prp22 with 30 min of pre-incubation, the levels have not declined much 10 min after auxin addition. Comparing this with 40 min of pre-incubation and 15 min with IAA, where there is little additional depletion, there is no benefit in incubating with auxin longer than 10 min or pre-incubating for longer than 30 min, particularly as there is evidence of non-auxin dependent depletion at 40 min. For Dcp1 with 40 min of pre-incubation (the last point at which the protein level is approximately 100% before auxin addition), 15 to 20 min of depletion with auxin is acceptable. It is recommended to keep the depletion time as short as possible to reduce secondary effects on cell metabolism 14 .
This article demonstrates how to use the β-est AID system by optimizing the timing of β-estradiol incubation for osTIR expression to achieve rapid target protein depletion upon IAA addition without depletion before adding auxin.
Protocol NOTE: See Figure 2 for a graphical summary.
Strain Preparation
1. Using a ura3-strain, introduce the β-est AID system (i.e., genes encoding the β-estradiol responsive transcription factor (ATF) and the osTIR) and AID* tag the target protein (see Figure 3 and Table 1 for a summary of the procedure).
Transform 15 either pZTRK (G418 resistance marker) or pZTRL (LEU2 marker) plasmid (available from the Yeast Genetic Resource
Centre) into the ura3-yeast strain or use the plasmid as a template to produce the PCR product for genomic integration. 2. PCR amplify the ATF (marked Z4EVATF on the plasmid map) and osTIR using a high fidelity polymerase from either of the plasmids pZTRK or pZTRL. Use primers with 50 to 60 base 3' extensions with homology to the genomic region, to direct integration by homologous recombination 16 . For genomic integration of the two components either separately or together, see Table 1 for primers and conditions. NOTE: The strain pZ4EV-NTR1 has the components already integrated in the genome (available from the Yeast Genetic Resource Centre, Japan). 3. Ensure that the target protein is AID* tagged using the Longtine procedure 17 (see Figure 3b and Table 1 ). 4 . Perform a growth analysis on the strain without β-estradiol and IAA present to determine if the AID* tag affects growth and to predict growth rate for use at step 1.5. 4. Anticipate the culture's growth. The target OD for collecting the samples is approximately 0.7 to 0.8, but the pre-incubation step (the incubation with β-estradiol to induce the osTIR), needs to be started earlier so that the culture will reach approximately the right OD by the time the samples are collected. NOTE: It is advisable to perform a growth curve in the conditions to be used in the experiment so that this starting OD can be estimated. 5. Once the target OD for the start of the pre-incubation has been reached, take a sample (usually 10 mL), into the pre-prepared tube containing cold methanol. Invert briefly to mix and place back in dry ice. NOTE: The sample can be moved to water ice after about 5 min, if convenient to do so. 6. Immediately add the β-estradiol, 1 µL/mL of culture (final concentration of 10 µM); have the β-estradiol pre-measured in a pipette ready for use in order to reduce the time taken between collecting the sample and adding the β-estradiol. Rapidly mix by swirling vigorously. 7. Continue to grow the culture as before (step 2.2), incubate (this is the "pre-incubation" step) with β-estradiol for the optimal time (for determination of the optimal pre-incubation time see Figure 1 ). 8. Prepare to add IAA (auxin). Take up the volume of IAA needed for step 2.10 (i.e., 0.5 µL of IAA per mL of culture). This makes step 2.20 faster. Either a single sample, at a time when it is expected that the protein will be reliably depleted, or multiple samples in a time course of depletion. For example, 5 min intervals are convenient for timing and provide a range of protein levels. The optimization strategy, as shown in Figure 1 , will give an indication of suitable times. 12. Process the samples.
General Procedure for Depletion
1. Place the samples on ice, if not done already. Ensure that none of the samples has frozen; if they have, gently warm in the hand, inverting constantly so the temperature does not rise locally. NOTE: This is best done in the hand as the sample's temperature can be assessed, it should always feel cold. Place on ice. This is not a pause point -once all the samples are fluid, proceed to the next step. 2. Once all samples have been collected and are no longer frozen, spin at 3,500 x g for 2 min (at 4 °C if possible). 3. Pour off the methanol/medium mix and place back on ice; do not worry if not all the liquid has been removed. 4. Resuspend the cell pellet in 1 mL of ice cold H 2 O (from step 2.3.3) and transfer to a labelled 1.5 mL tube (prepared in step 2.3.2) on ice. 5. Spin briefly (e.g., 10 s total time) at >15,000 x g to re-pellet the cells, place back on ice and remove the liquid. 6. Remove the H 2 O by aspiration. The cell pellets can be stored at -20 °C, or -80 °C for long term storage. 13 . Check the level to which the protein has been depleted by Western blot analysis 18 . NOTE: Sufficient protein 19 and/or nucleic acid can be extracted from a single cell pellet for most purposes, although rare RNA species might require more sample volume.
Representative Results
Representative examples of depletion are displayed in Figure 1 . The three experiments presented in this figure were optimization experiments for depletion of the proteins Prp2, Prp22 and Dcp1. The low abundance, spliceosomal Prp2 and Prp22 proteins both depleted to less than 20% after 40 min pre-incubation with β-estradiol followed by 15 min with auxin. Longer pre-incubation times lead to faster depletion but also show undesirable protein depletion before auxin addition. In comparison, the more abundant Dcp1 was only depleted to approximately 30% with the same treatment, but 60 min of pre-incubation resulted in depletion to 13% with the same auxin treatment, at the cost of depletion before the auxin is added. It is possible that 50 min of pre-incubation with β-estradiol and 15 min with auxin would have achieved similar results at a shorter time point and so would have been more optimal. pZRTL/K is to amplify the β-est AID system pURA3-AID*-6FLAG/6HA to amplify the AID* and epitope tag to tag the target protein (Lontine procedure) <-region of homology-> Region homologous to the flanking regions where the system is to be inserted. The longer this region is the more likely the modification is to be successful; 50 -100 bases is recommended.
<-region of homology (RC)-> Region homologous to the flanking regions where the system is to be inserted, remember to use the reverse complement. As above, the longer this region is the better. 
Discussion
A well optimized protocol can produce rapid and efficient depletion of the target protein. Determining the approximate pre-incubation time with βestradiol is important, as this increases reproducibility of the depletion, but small variations in pre-incubation time can be tolerated. On the other hand, care must be taken with timing after auxin addition, as the protein level declines very rapidly.
An advantage of this approach is that tuned depletion can be achieved by varying combinations of pre-incubation time with β-estradiol and IAA incubation time. For example, if desired, the target protein can be more slowly depleted by reducing the pre-incubation time.
The β-est AID system offers certain advantages over systems where OsTIR is constitutively expressed. For example, if the target protein is essential for viability, regulated expression of osTIR can avoid premature depletion of the target protein. Moreover, expression of osTIR can be tuned to suit the abundance of the target protein and its susceptibility to degradation, and the depletion can be either fast or slow. The two small molecule effectors, β-estradiol and auxin, do not perturb the yeast metabolism under the conditions used here, unlike rapamycin, used in the anchor-away system 1 .
It should be noted that tagging some proteins disrupts their function, which is a problem with any targeted depletion system. In this case, an Nterminal tag may work when a C-terminal tag does not. Also, not all proteins will be depleted efficiently; for example, the AID-tag on the target protein may be inaccessible to the osTIR protein. Therefore, after AID-tagging, each target protein should be tested for any effect of the tag on growth, and to determine whether depletion is effective, before the timings of β-estradiol pre-incubation and auxin treatment are optimized. This AID* system is very simple and is compatible with any subsequent experimental procedure that does not involve further growth, such as protein, DNA or RNA analysis or microscopy. In addition, the system works well when combined with thiolabelling to purify nascent RNA 20 .
This system provides a rapid, specific, and reproducible means of depleting a protein without otherwise affecting the metabolism of the yeast cell.
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